CELLDEX THERAPEUTICS INC NEW

Ticker: CLDX CUSIP: 15117B202 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 276,728 Value ($000) $9,406 Avg Close $38.10 Range $28.51 - $47.00

Q2 2024

Shares 1,377,868 Value ($000) $50,995 Avg Close $37.73 Range $32.25 - $43.35

Q1 2024

Shares 898,800 Value ($000) $37,723 Avg Close $41.06 Range $34.65 - $53.18

Q4 2023

Shares 1,280,084 Value ($000) $50,768 Avg Close $29.41 Range $22.11 - $41.47

Q3 2023

Shares 538,319 Value ($000) $14,815 Avg Close $31.35 Range $24.89 - $38.33

Q2 2023

Shares 289,523 Value ($000) $9,824 Avg Close $33.70 Range $29.68 - $39.29

Q1 2023

Shares 333,666 Value ($000) $12,005 Avg Close $43.15 Range $33.83 - $48.40

Q4 2022

Shares 666,749 Value ($000) $29,717 Avg Close $35.70 Range $27.01 - $46.04

Q3 2022

Shares 652,721 Value ($000) $18,348 Avg Close $30.66 Range $21.65 - $38.52

Q2 2022

Shares 20,023 Value ($000) $539 Avg Close $29.04 Range $19.85 - $37.95

Q1 2021

Shares 20,580 Value ($000) $423 Avg Close $22.96 Range $15.37 - $30.17

Q4 2020

Shares 12,023 Value ($000) $211 Avg Close $18.00 Range $14.40 - $23.40

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	276,728	$9,406	$38.10	$28.51 - $47.00
Q2 2024	1,377,868	$50,995	$37.73	$32.25 - $43.35
Q1 2024	898,800	$37,723	$41.06	$34.65 - $53.18
Q4 2023	1,280,084	$50,768	$29.41	$22.11 - $41.47
Q3 2023	538,319	$14,815	$31.35	$24.89 - $38.33
Q2 2023	289,523	$9,824	$33.70	$29.68 - $39.29
Q1 2023	333,666	$12,005	$43.15	$33.83 - $48.40
Q4 2022	666,749	$29,717	$35.70	$27.01 - $46.04
Q3 2022	652,721	$18,348	$30.66	$21.65 - $38.52
Q2 2022	20,023	$539	$29.04	$19.85 - $37.95
Q1 2021	20,580	$423	$22.96	$15.37 - $30.17
Q4 2020	12,023	$211	$18.00	$14.40 - $23.40